Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Administrative updates were made to study record dates and the last verified timestamp. The core interventions, outcomes, and eligibility criteria remain unchanged.
    Difference
    0.1%
    Check dated 2025-10-29T10:05:39.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Version bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.
    Difference
    2%
    Check dated 2025-10-06T15:56:04.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T09:52:28.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; a 'Back to Top' element was removed. No core content, pricing, stock, or time slots were altered.
    Difference
    0.1%
    Check dated 2025-09-14T23:56:47.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T20:39:04.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as references to renal cell carcinoma and related studies. Several previous locations and terms have been removed, indicating a potential reorganization or focus shift in the content.
    Difference
    14%
    Check dated 2025-08-31T12:57:54.000Z thumbnail image

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.